NASDAQ Financial Services Asset Management GENB

Generate Biomedicines, Inc.

GENB

Finances

	2025	2024
Revenue	31.893 M ^{55.89 %}	20.459 M
Net income	-203.154 M ^{-16.91 %}	-173.771 M
EBITDA	-208.488 M ^{-27.36 %}	-163.705 M
Weighted average shs out dil	50.089 M ^{-60.70 %}	127.450 M
Weighted average shs out	50.089 M ^{-60.70 %}	127.450 M
EPS diluted	-4.98 ^{-196.43 %}	-1.68
Earnings per share	-4.98 ^{-196.43 %}	-1.68
Gross profit	31.893 M ^{55.89 %}	20.459 M
Income tax expense	163.000 K ^{-23.11 %}	212.000 K
Cost of revenue	0.000	0.000
General and administrative expenses	42.260 M ^{0.41 %}	42.087 M
Selling and marketing expenses	0.000	0.000
Other expenses	0.000	0.000
Operating expenses	266.958 M ^{22.80 %}	217.398 M
Cost and expenses	266.958 M ^{22.80 %}	217.398 M
Research and development expenses	224.698 M ^{28.17 %}	175.311 M
Selling general and administrative expenses	42.260 M ^{0.41 %}	42.087 M
Interest income	13.661 M ^{-24.60 %}	18.118 M
Interest expense	1.136 M ^{-46.36 %}	2.118 M
Depreciation and amortization	13.178 M ^{-14.14 %}	15.349 M
Operating income	-235.065 M ^{-19.36 %}	-196.939 M
Total other income expenses net	12.263 M ^{-22.22 %}	15.767 M
	2025	2024

	2025	2024
Net debt	-53.124 M ^{46.50 %}	-99.297 M
Total investments	99.848 M ^{-54.06 %}	217.358 M
Total debt	68.526 M ^{-10.97 %}	76.972 M
Accumulated other comprehensive income loss	106.000 K ^{-10.17 %}	118.000 K
Retained earnings	-676.293 M ^{-42.94 %}	-473.139 M
Common stock	50.000 K ^{0.00 %}	50.000 K
Total equity	-623.197 M ^{-43.23 %}	-435.090 M
Other non current liabilities	813.147 M ^{2.76 %}	791.294 M
Long term debt	0.000	0.000
Total non current liabilities	871.176 M ^{0.51 %}	866.723 M
Other current liabilities	16.426 M ^{4.07 %}	15.783 M
Deferred revenue	21.194 M ^{-50.04 %}	42.425 M
Short term debt	0.000	0.000
Total current liabilities	82.203 M ^{-5.11 %}	86.626 M
Total liabilities	953.379 M ^{0.00 %}	953.349 M
Other non current assets	6.806 M ^{-29.84 %}	9.700 M
Long term investments	0.000	0.000
Intangible assets	0.000	0.000
GoodWill	0.000	0.000
Goodwill and intangible assets	0.000	0.000
Property plant equipment net	89.011 M ^{-11.93 %}	101.068 M
Total non current assets	95.817 M ^{-13.50 %}	110.768 M
Other current assets	12.867 M ^{-5.08 %}	13.556 M
Short term investments	99.848 M ^{-54.06 %}	217.358 M
cash and cash equivalents	121.650 M ^{-30.99 %}	176.269 M
Cash and short term investments	221.498 M ^{-43.73 %}	393.627 M
Total current assets	234.365 M ^{-42.49 %}	407.491 M
Inventory	0.000	0.000
Net receivables	0.000 ^{-100.00 %}	308.000 K
Tax assets	0.000	0.000
Other assets	0.000	0.000
Account payables	3.837 M ^{-32.29 %}	5.667 M
Tax payables	0.000	0.000
Deferred revenue non current	4.511 M ^{-70.27 %}	15.174 M
Minority interest	-7.232 M ^{-1 166.55 %}	-571.000 K
Capital lease obligations	68.526 M ^{-10.97 %}	76.972 M
Preferred stock	0.000	0.000
Other total stockholders equity	0.000	0.000
Deferred tax liabilities non current	0.000	0.000
Other liabilities	0.000	0.000
Total assets	330.182 M ^{-36.29 %}	518.259 M
	2025	2024

	2025	2024
Deferred income tax	0.000	0.000
Stock based compensation	20.577 M ^{5.71 %}	19.465 M
Change in working capital	-14.616 M ^{-151.98 %}	28.118 M
Accounts receivables	308.000 K ^{244.60 %}	-213.000 K
Inventory	0.000	0.000
Accounts payables	-2.130 M ^{-160.87 %}	3.499 M
Other working capital	-12.794 M ^{-151.52 %}	24.832 M
Other non cash items	3.207 M ^{356.84 %}	702.000 K
Net cash provided by operating activities	-200.619 M ^{-70.38 %}	-117.750 M
Investments in property plant and equipment	-3.514 M ^{-1.94 %}	-3.447 M
Acquisitions net	0.000	0.000
Purchases of investments	-164.731 M ^{41.79 %}	-282.979 M
Sales maturities of investments	285.012 M ^{24.63 %}	228.691 M
Other investing activites	0.000 ^{-100.00 %}	10.000 K
Net cash used for investing activites	116.767 M ^{302.28 %}	-57.725 M
Debt repayment	-8.161 M ^{26.64 %}	-11.124 M
Common stock issued	0.000	0.000
Common stock repurchased	0.000	0.000
Dividends paid	0.000	0.000
Other financing activites	14.247 M ^{132.53 %}	6.127 M
Net cash used provided by financing activities	28.059 M ^{-69.28 %}	91.327 M
Effect of forex changes on cash	0.000	0.000
Net change in cash	-55.793 M ^{33.70 %}	-84.148 M
Cash at beginning of period	181.831 M ^{-31.64 %}	265.979 M
Cash at end of period	126.038 M ^{-30.68 %}	181.831 M
Operating cash flow	-200.619 M ^{-70.38 %}	-117.750 M
Capital expenditure	-3.514 M ^{-1.94 %}	-3.447 M
Free CashFlow	-204.133 M ^{-68.43 %}	-121.197 M
	2025	2024

	2026-03-31
Revenue	7.224 M
Net income	-61.446 M
Income before tax	-61.686 M
EBITDA	-60.839 M
Weighted average shs out dil	128.192 M
Weighted average shs out	128.192 M
EPS diluted	-0.54
Earnings per share	-0.54
Gross profit	3.951 M
Income tax expense	28.000 K
Cost of revenue	3.273 M
General and administrative expenses	0.000
Selling and marketing expenses	0.000
Other expenses	0.000
Operating expenses	68.063 M
Cost and expenses	71.336 M
Research and development expenses	54.561 M
Selling general and administrative expenses	13.502 M
Interest income	2.913 M
Interest expense	182.000 K
Depreciation and amortization	3.273 M
Operating income	-64.112 M
Total other income expenses net	2.426 M
	2026-03-31

	2026-03-31
Net debt	-95.005 M
Total investments	356.066 M
Total debt	65.570 M
Accumulated other comprehensive income loss	24.000 K
Retained earnings	-737.739 M
Common stock	128.000 K
Total equity	514.801 M
Other non current liabilities	0.000
Long term debt	0.000
Total non current liabilities	52.547 M
Other current liabilities	14.920 M
Deferred revenue	17.244 M
Short term debt	14.261 M
Total current liabilities	58.389 M
Total liabilities	110.936 M
Other non current assets	4.745 M
Long term investments	0.000
Intangible assets	0.000
GoodWill	0.000
Goodwill and intangible assets	0.000
Property plant equipment net	85.602 M
Total non current assets	90.347 M
Other current assets	18.749 M
Short term investments	356.066 M
cash and cash equivalents	160.575 M
Cash and short term investments	516.641 M
Total current assets	535.390 M
Inventory	0.000
Net receivables	0.000
Tax assets	0.000
Other assets	0.000
Account payables	7.617 M
Tax payables	0.000
Deferred revenue non current	1.238 M
Minority interest	0.000
Capital lease obligations	51.309 M
Preferred stock	0.000
Other total stockholders equity	0.000
Deferred tax liabilities non current	0.000
Other liabilities	0.000
Total assets	625.737 M
	2026-03-31

	2026-03-31
Deferred income tax	0.000
Stock based compensation	0.000
Change in working capital	-30.653 M
Accounts receivables	0.000
Inventory	0.000
Accounts payables	3.754 M
Other working capital	-34.407 M
Other non cash items	8.438 M
Net cash provided by operating activities	-80.388 M
Investments in property plant and equipment	-3.781 M
Acquisitions net	7.500 M
Purchases of investments	-321.153 M
Sales maturities of investments	65.000 M
Other investing activites	0.000
Net cash used for investing activites	-252.434 M
Debt repayment	-1.115 M
Common stock issued	372.506 M
Common stock repurchased	0.000
Dividends paid	0.000
Other financing activites	0.000
Net cash used provided by financing activities	371.391 M
Effect of forex changes on cash	122.006 M
Net change in cash	160.575 M
Cash at beginning of period	0.000
Cash at end of period	160.575 M
Operating cash flow	-80.388 M
Capital expenditure	-3.781 M
Free CashFlow	-84.169 M
	2026